1. Abstract submission is open to both local and international delegates.
2. All abstracts submitted must be in English.
3. Once an abstract is selected, at least one of the authors of the poster MUST register for the conference. Payment for conference registration should reach the Conference Secretariat before 30^th June 2023 to ensure that your abstracts will be published in the e-abstract book.
4. The abstract title should not exceed 120 characters.
5. The abstract should not exceed 300 words.
6. Abstracts submitted must follow the abstract submission guidelines, instructions and required information as stated. The MAC 13 Scientific Committee reserves the rights to disqualify the abstract if any needs are not met.
7. Encore Abstracts will not be accepted. Encore abstract is a re-submission of an original abstract with minor changes in line with congress guidelines.
   
   **Encore abstract is a paper where the research is done by another party and has a doctor to put their name as the author of the abstract.
   
   
8. For further details on registration, fees and payments for the conference, kindly visit www.memsmac.org

1. Please read the instructions carefully, as abstracts submitted not according to these instructions will not be accepted.
2. Abstracts can only be submitted electronically through the official Conference website (www.memsmac.org). Abstract sent by post, fax or email WILL NOT BE ACCEPTED. Delegates may submit more than ONE abstract (please use the same email address).
3. Only submissions received by 15th May 2023 will be eligible for Best Oral & Best Poster prizes.
4. Your abstract will be published in the e-abstract/e-programme book as submitted. Please ensure you check your data carefully before submitting.
5. Please contact the Conference Secretariat at abstracts@memsmac.org should you need any assistance.
6. All submitted abstracts will undergo a peer-review process by a panel of expert reviewers. Accepted abstracts will be selected for either oral or poster presentations. The MAC 13 Scientific Committee reserves the right to re-categorise any accepted abstract. The decision of the committee is final and irrevocable. All accepted abstracts will be printed in the Journal of the ASEAN Federation of Endocrine Societies (JAFES).
7. Authors will be notified of the method of presentation, which will be decided by the MAC 13 Scientific Committee.
8. Abstract submitters will be informed of the status of their abstracts once the reviewing process is completed.
9. Judges’ decisions are final. No appeal will be entertained.

Upon submitting your abstracts for Oral Presentation, your abstract might be selected for Young Investigators Award if you meet the following conditions:

1. The first author/presenter must be 40 years old or less
2. The work submitted may be from any related topics for MAC 13.
3. The bulk of work which is submitted must be performed by the author himself/herself.
4. Authors of submitted abstracts are required to register for the congress.
5. The author himself/herself should present the paper during the congress as a finalist for the Young Investigator Award.

A panel of judges shall decide on the winners and the judges’ decision is final.

1. Adult
• Diabetes mellitus
• Obesity
• Thyroid
• Adrenal
• Pituitary/Neuroendocrinology
• Parathyroid/Bone & Calcium Metabolism
• Reproductive Endocrinology
• Others (please specify)
2. Paediatric
3. Basic Science [Including Covid & Endocrine Diseases]

Select the category which BEST describes the content of your abstract. Categories are used for reviewing and indexing purposes.

The title is limited to 120 characters excluding spaces and should be brief and relevant. Special characters should NOT be used in your title but spelt out instead (e.g. α should be written as alpha, β as beta). Only use standard abbreviations and generic drug names in the title. Capitalise each word in the title.

1. Structure: The abstract should have the following sub-headings: - Introduction, Methods, Results, and Conclusion.
2. Layout: Please fill in according to the sections provided. Do not include graphs, tables or illustrations in the abstract.
3. Word count: The abstract is limited to 300 words.
4. Only commonly accepted abbreviations should be used (e.g. OGTT, IGT, ACEI). Less widely recognized abbreviations may be used if introduced on first usage (e.g. ambulatory blood pressure monitoring, ABPM).
5. Only approved and generic (non-proprietary) drug names should be used.
6. Do NOT enter the title, authors, or grant information into the abstract body submission field.

Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be published in the e-abstract/e-programme book exactly as submitted.